Kareem Ali Maher et al. 2023. Cardiovascular Risk Assessment after Sofosbuvir and Daclatasvir Regimen for Chronic Hepatitis C Virus Infection. Journal of the Pakistan Medical Association. 73, 4 (May 2023), S136-S141. DOI:https://doi.org/10.47391/JPMA.EGY-S4-28.